• SCUBE3 Antibody Targeting Rewires Tumor Progression

  2026-08-18

  The reference study identifies secreted SCUBE3 as a convergent driver of oncogenic signaling, therapy resistance, and immune suppression. Its neutralizing antibody strategy blocked SCUBE3-associated receptor signaling, reduced tumor progression, and restored antitumor immune features in preclinical models, supporting SCUBE3 as a candidate pan-cancer target.

• Cy5-UTP Workflow for Neuronal RNA Probes

  2026-08-17

  Cy5-UTP enables direct far-red visualization of RNA probes produced by T7 in vitro transcription, making it useful for FISH, neuronal localization studies, and dual-color expression arrays. This guide connects practical probe synthesis and troubleshooting with a recent study of axonal RNP trafficking while clearly separating validated findings from assay-development recommendations.

• SEMA3E, β-Catenin, and Beige Thermogenesis

  2026-08-16

  A 2026 mouse study identifies the secreted semaphorin SEMA3E as a regulator of beige adipocyte differentiation and non-shivering thermogenesis in inguinal white adipose tissue. Through genetic perturbation, transplantation, AAV-mediated knockdown, transcriptomics, respiration assays, and pathway rescue experiments, the authors connect SEMA3E activity to mitochondrial oxidative phosphorylation and β-catenin turnover.

• Octenidine Dihydrochloride: Assay Logic

  2026-08-15

  Octenidine dihydrochloride is more than a broad-spectrum antiseptic benchmark. This article explains how its molecular architecture, membrane-disruption mechanism, and recent gemini QAC evidence can guide interpretable antimicrobial assay design.

• Trelagliptin, RUNX2, and Osteoblast Differentiation

  2026-08-15

  The reference study reports that the DPP-4 inhibitor trelagliptin enhances osteoblastic differentiation and mineralization in MC3T3-E1 cells by increasing RUNX2 through an AMPK-associated mechanism. Its findings support drug repurposing as a hypothesis for osteoporosis research, while the in vitro design requires validation in more physiologically relevant models.

• Cyanidin Chloride in Oxidative Stress Workflows

  2026-08-14

  Cyanidin Chloride gives researchers a practical way to connect radical-scavenging assays with inflammatory signaling and epithelial barrier endpoints. This workflow translates anthocyanin biology into reproducible HaCaT and RAW264.7 experiments while highlighting identity, solubility, color interference, and dose-optimization controls.

• CHIR-99021 Workflows for Stem Cell Signaling

  2026-08-14

  CHIR-99021 (CT99021) gives researchers a tunable way to activate canonical Wnt signaling while connecting pluripotency, lineage specification, and vascular organoid assays. This practical guide combines benchmark treatment conditions with stage-aware controls inspired by recent high-glucose blood vessel organoid research.

• Phalloidin B7678: F-Actin Workflow Guide

  2026-08-13

  Phalloidin (B7678) is a high-affinity F-actin probe for stabilizing and visualizing filamentous actin in fixed or permeabilized samples. It supports endpoint cytoskeleton analysis but should not be used for live-cell imaging or experiments that require reversible, unperturbed actin dynamics.

• CGP 55845 Hydrochloride: GABAB Assay Guide

  2026-08-13

  CGP 55845 hydrochloride is a potent, selective GABAB receptor antagonist for in vitro neurotransmission assay design. Its documented pharmacology supports neurotransmitter release modulation studies, while the astrocytic GAT-3 findings provide biological context rather than evidence that this compound directly inhibits GAT-3.

• THZ1 Workflows for CDK7 Transcription Research

  2026-08-12

  THZ1 is a covalent CDK7 inhibitor for connecting rapid transcriptional disruption with durable antiproliferative and apoptosis outcomes. This guide presents practical workflows for T-ALL, cancer biology, and exploratory adipogenesis studies, with dosing logic, controls, and troubleshooting safeguards.

• Salvianolic Acid B and the Mechanics of Fibrosis

  2026-08-12

  Salvianolic acid B, also known as Dan Shen Suan B, is emerging as a mechanistically informative research tool for pulmonary fibrosis. This article examines LH2-driven collagen cross-linking, interprets recent validation data, and outlines translational workflows for extracellular matrix remodeling studies.

• DZNep: Mechanism-Led Design of Epigenetic Assays

  2026-08-11

  3-Deazaneplanocin (DZNep) is more than a generic epigenetic modulator: its linked SAHH, EZH2, chromatin, and phenotype effects require a layered assay strategy. This guide connects mechanistic interpretation with AML, liver cancer, and translational study design.

• Auranofin in Mechanics-Aware Redox Research

  2026-08-10

  Auranofin is a thioredoxin reductase inhibitor for dissecting redox-dependent apoptosis, radiosensitization, and antimicrobial responses. This guide adds a mechanics-aware framework that helps researchers separate oxidative-stress effects from cytoskeleton-dependent autophagy in complex cell assays.

• Netarsudil (AR-13324) for ROCK–siRNA Workflows

  2026-08-09

  Netarsudil (AR-13324) combines potent ROCK inhibition with a distinctive opportunity for siRNA co-encapsulation in research nanoparticles. This practical guide connects trabecular meshwork assays, predictive formulation screening, and troubleshooting for synchronized control of CTGF expression and actin remodeling.

• Self-Adaptive Nanocarriers in Pancreatic Cancer

  2026-08-08

  The ACS Nano study develops DATCPT, a pH/reactive oxygen species-responsive nanocarrier designed to overcome circulation, stromal, penetration, and metastatic barriers in orthotopic pancreatic cancer. Its sequential charge activation, ROS-dependent matrix remodeling, and camptothecin delivery provide a useful framework for interpreting redox biology in nanomedicine while highlighting the need for mechanistically specific ROS controls.

457 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page